Zdrowie i gospodarka · 11/06/2019
Quality Considerations for Continuous Manufacturing; Draft Guidance for Industry; Availability; Reopening of Comment Period
The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the notice entitled "Quality Considerations for Continuous Manufacturing; Draft Guidance for Industry; Availability" that appeared in the Federal Register of February 27, 2019. The Agency is taking this action to allow interested persons additional time to submit comments.